13F Holdings
中文EN

ASTH Astrana Health, Inc.

Services-Management Consulting Services · Nasdaq · SEC CIK 1083446 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY35.1%
TTM net income YoY457.1%
TTM EPS YoY468.4%
Revenue 3-yr CAGR43.4%
Net income 3-yr CAGR6.0%

Margins

Gross margin11.0%
Operating margin3.1%
Net margin1.4%
FCF margin2.5%
EBITDA margin4.7%

Returns

ROE6.5%
ROA2.3%
ROIC (approx.)5.9%
Asset turnover1.71x

Leverage & solvency

Liabilities / assets73.1%
Debt / equity1.08x
Current ratio1.25x
Interest coverage1.87x

Cash quality & payout

Operating cash flow / net income2.15x
Accruals ratio-2.7%
Payout ratio5.1%
Capex / revenue0.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$3.18B$2.03B$1.39B$1.14B$773.91M
Cost of revenue$2.84B$1.76B$1.17B$944.68M$596.14M
Gross profit$341.53M$271.39M$214.96M$199.48M$177.77M
SG&A expense$217.26M$154.11M$112.60M$77.67M$62.08M
Operating income$78.53M$89.35M$84.61M$104.27M$98.18M
Interest expense$49.93M$33.10M$16.10M$7.92M$5.39M
Pretax income$39.61M$80.82M$89.84M$86.62M$77.75M
Income tax$15.53M$30.89M$31.99M$40.88M$31.69M
Net income$22.49M$43.15M$60.72M$45.17M$68.92M
EBITDA$124.27M$117.28M$102.36M$121.81M$115.70M
EPS (basic)0.460.911.301.001.57
EPS (diluted)0.460.901.290.991.52
Weighted avg. shares (diluted)49.37M47.97M46.94M45.60M45.40M
Balance sheet
Cash & equivalents$429.47M$289.10M$293.81M$288.03M$233.10M
Short-term investments—$2.38M$2.50M$5.57M$53.42M
Receivables$374.46M$275.99M—$49.63M$10.61M
Current assets$863.31M$638.50M$461.51M$428.12M$404.46M
PP&E, net$57.33M$14.27M$7.17M$108.54M$53.19M
Goodwill$865.30M$419.25M$278.83M$269.05M$246.42M
Intangibles$270.97M$118.18M$71.65M$76.86M$82.81M
Total assets$2.22B$1.35B$933.36M$966.21M$867.36M
Current liabilities$615.27M$365.61M$218.67M$148.61M$114.72M
Short-term debt$47.87M$9.38M$19.50M$619,000$780,000
Long-term debt$990.90M$425.30M$258.94M$203.39M$182.92M
Total debt$1.04B$434.67M$278.44M$204.01M$183.70M
Total liabilities$1.66B$840.73M$522.59M$407.67M$356.72M
Shareholders' equity$779.29M$712.72M$614.22M$542.56M$448.17M
Net debt$609.29M$145.57M-$15.37M-$84.02M-$49.40M
Shares outstanding48.89M47.93M—46.58M44.63M
Cash flow statement
Operating cash flow$114.60M$52.20M$68.23M$82.13M$70.33M
Capital expenditure$10.11M$8.03M$28.53M$22.94M$19.22M
Free cash flow$104.49M$44.17M$39.70M$59.19M$51.11M
Investing cash flow-$539.00M-$192.40M-$65.52M-$7.11M$16.54M
Financing cash flow$569.35M$135.15M$3.42M-$20.09M-$47.75M
Depreciation & amortization$45.75M$27.93M$17.75M$17.54M$17.52M
Stock-based compensation$38.60M$34.54M$22.04M$16.10M$6.75M
Dividends paid$7.88M$4.04M$62.07M$14.03M$31.09M
Share buybacks$25.60M$900,000$10.19M$9.25M$5.74M

Free plan shows the latest 5 periods; Pro shows all 17 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.